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CpG islands (CGIs) are prominent in the mammalian genome owing to their GC-rich base composition and high density of CpG dinucleotides 1,2 . Most human gene promoters are embedded within CGIs that lack DNA methylation and coincide with sites of histone H3 lysine 4 trimethylation (H3K4me3), irrespective of transcriptional activity 3, 4 . In spite of these intriguing correlations, the functional significance of non-methylated CGI sequences with respect to chromatin structure and transcription is unknown. By performing a search for proteins that are common to all CGIs, here we show high enrichment for Cfp1, which selectively binds to nonmethylated CpGs in vitro 5, 6 . Chromatin immunoprecipitation of a mono-allelically methylated CGI confirmed that Cfp1 specifically associates with non-methylated CpG sites in vivo. High throughput sequencing of Cfp1-bound chromatin identified a notable concordance with non-methylated CGIs and sites of H3K4me3 in the mouse brain. Levels of H3K4me3 at CGIs were markedly reduced in Cfp1-depleted cells, consistent with the finding that Cfp1 associates with the H3K4 methyltransferase Setd1 (refs 7, 8) .
To test whether non-methylated CpG-dense sequences are sufficient to establish domains of H3K4me3, we analysed artificial CpG clusters that were integrated into the mouse genome. Despite the absence of promoters, the insertions recruited Cfp1 and created new peaks of H3K4me3. The data indicate that a primary function of non-methylated CGIs is to genetically influence the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.
To characterize the chromatin modifications typical of CGIs, we used the methyl-CpG-sensitive restriction endonuclease HinPI (cleavage site GCGC) to release small chromatin fragments from purified brain nuclei, as described previously 9 . As sites for this enzyme in bulk chromatin are rare and generally uncleavable owing to DNA methylation, the released fraction predominantly contains non-methylated CGIs. Confirming this, further digestion of the deproteinized DNA with HpaII (cleavage site CCGG) specifically collapsed the nucleosomal ladder generated by HinPI, but had little effect on DNA released from bulk chromatin with MseI (cleavage site TTAA; Supplementary Fig. 1 ) 9 . Western blotting confirmed that non-methylated CGI chromatin is enriched for histone modifications associated with actively transcribed genes (acetylated histone H3, H3K4me3 and H3K4me2) compared with bulk chromatin (Fig. 1a) . In contrast, CGI chromatin was depleted for marks not found at active promoters: H3K36me3, H3K9me3, H3K27me3 and H4K20me3 (Fig. 1a) . Agreement between these results and genomewide studies of chromatin modifications 3,4,10,11 indicated that this fraction could be used to identify proteins that preferentially localize to non-methylated CGIs. We first tested CXXC finger protein 1 (Cfp1), which binds to non-methylated CpG dinucleotides in vitro by a CXXC zinc finger domain 6, 12 . The data showed that Cfp1 is enriched within the CGI fraction of the genome (Fig. 1a) . Similarly, Kdm2a, an H3K36 demethylase that also contains a CXXC domain 13 , was enriched in the CGI fraction. Focusing on Cfp1, we tested its in vivo binding specificity by chromatin immunoprecipitation (ChIP) at an endogenous CGI that is present in both methylated and non-methylated states. The Xist CGI is mono-allelically methylated in female cells, but fully methylated in males, which only have one X chromosome 14 . ChIP analysis of mouse brain tissue identified a peak of Cfp1 binding over the Xist CGI in females, but no peak was present in males, suggesting that Cfp1 exclusively binds to the non-methylated allele (Fig. 1b) . To test this more stringently, we used bisulphite sequencing across the Xist locus to determine the methylation status of the immunoprecipitated chromatin recovered from females. As expected, input DNA comprised equal numbers of methylated and non-methylated DNA clones. DNA immunoprecipitated by the Cfp1 antibody was almost exclusively non-methylated (96%), however, whereas DNA immunoprecipitated with an antibody against the methyl-CpG-binding protein MeCP2 (refs 15-17) was predominantly methylated (88%; Fig. 1c) . We conclude that Cfp1 selectively binds to non-methylated CpGs in vivo.
To test whether Cfp1 is concentrated at non-methylated CpGs within CGIs, we analysed the genome-wide distribution of Cfp1 using high-throughput DNA sequencing of immunoprecipitated DNA (ChIP-Seq). Prominent peaks of Cfp1 binding co-localized with non-methylated CGIs (Fig. 2a) , 81% of which were Cfp1-associated. Cfp1 has been identified as part of the Setd1 H3K4 methyltransferase complex 8 and ChIP-Seq with H3K4me3 antibodies showed that 93% of Cfp1-bound CGIs also possess this histone modification ( Fig. 2b and Supplementary Table 1) . Consistent with the possibility that Cfp1 binding is responsible for recruiting the Setd1 complex to these sites, Cfp1-negative non-methylated CGIs (19% of the total) also lack H3K4me3 (Fig. 2b) . Despite being rich in non-methylated CpGs, these CGIs are somehow refractory to Cfp1 binding. One potential explanation came from alignment with the published 18 distribution of the polycomb-associated mark H3K27me3 (ref. 19 ) in mouse brain. More than half (58%) of Cfp1-negative and H3K4me3-negative CGIs contained the H3K27 modification (Fig. 2a, b and Supplementary Fig.  2 ). In these cases H3K27me3 and polycomb binding may render a CpG island refractory to Cfp1 binding and to H3K4 methylation.
To assess the importance of Cfp1 for the recruitment of H3K4me3, we used stably expressed short hairpin RNAs (shRNAs) directed against Cfp1 to reduce its level in NIH3T3 cells. Single shRNAs reduced Cfp1 ( Supplementary Fig. 3 ), but a combination of three gave a greater effect (Fig. 3a) . Depleted cells showed altered morphology ( Fig. 3b ) and retarded growth (Fig. 3c) . ChIP analysis revealed a loss of Cfp1 binding compared with vector-only transfected cells accompanied by a precipitous drop in levels of H3K4me3 across CGIs at the brain-derived neurotrophic factor (Bdnf), b-actin (Actb), c-Myc and Dlx5/6 genes ( Fig. 3d) . The same results were obtained with clones expressing each of two independent shRNA sequences, ruling out off-target effects of shRNA expression (Supplementary Fig. 3 ). As a further control, H3K27me3 profiles at the same loci were unaffected by depletion of Cfp1 ( Fig. 3d and Supplementary Fig. 3b ). The loss of H3K4me3 at six randomly selected CGI promoters in Cfp1-depleted cells argues that this modification is dependent on the presence of Cfp1.
Although Cfp1 binds non-methylated CpGs and seems to be required for H3K4 methylation at CGIs, it is possible that this reflects indirect recruitment of Setd1 by RNA polymerase II, which is present at active CGI promoters. Alignment of ChIP-Seq profiles for Cfp1, H3K4me3 and the unphosphorylated form of RNA polymerase II indeed showed co-localization of all three signals at 86% of all Cfp1-bound CGIs (Supplementary Table 1 and Supplementary Fig. 4 ). In a small proportion (7%) of cases, however, RNA polymerase II was undetectable, despite the presence of robust peaks of H3K4me3 and Cfp1 ( Supplementary Fig. 4 ). This raised the possibility that RNA polymerase II may not be required and that Cfp1 binding is sufficient to direct H3K4 trimethylation. To test this hypothesis, we used embryonic stem (ES) cell lines in which artificial promoterless CpG-rich DNA sequences had been introduced into the genome at sites that normally lack H3K4me3. The DNA insert in ES line TbC44 (ref. 20 ) comprises a 720-base-pair (bp) enhanced green fluorescent protein (eGFP) coding sequence containing 60 CpGs 21 adjacent to a 600-bp puromycinresistance gene with 93 CpGs (Fig. 4a) . The inserted sequence has the typical CpG density of a CGI, but lacks a promoter. Bisulphite analysis showed that integrated sequence is non-methylated (Fig. 4a) . In the targeted cells, prominent domains of Cfp1 and H3K4me3 coincided with the inserted CpG-rich DNA (Fig. 4b) . Interestingly, the peaks of H3K4me3 and Cfp1 tracked CpG density as expected if H3K4me3 is determined by this DNA dinucleotide sequence (Fig. 4b, broken line) . No peak of RNA polymerase was detected. An independent ES cell line carrying an eGFP insertion on the X chromosome 22 ( Fig. 4c ) also created a peak of H3K4me3 and Cfp1 (Fig. 4d) . In this case, bisulphite sequencing showed that approximately a quarter of the integrated sequences were hypomethylated and the remainder were densely methylated (Fig. 4e, input panel) . ChIP-bisulphite analysis demonstrated that Cfp1 and H3K4me3 antibodies significantly enriched the hypomethylated sequences (Fig. 4e) . We conclude that clusters of nonmethylated CpG are sufficient to recruit Cfp1 and create a peak of H3K4me3 modification, even in the absence of a promoter.
The density of non-methylated CpG is ,50-fold higher in CGIs than in bulk genomic DNA, as CpG in the latter is deficient (20% of expected 23 ) and mostly methylated (,70%). It is unclear whether this high CpG density arises as a passive consequence of events at promoters and has no functional significance, or whether it has been selected over evolutionary time because it facilitates transcription (or other DNA-related processes). Our results favour selection, as they indicate that CpG density per se can directly influence histone modification status by the recruitment of the Cfp1 protein and its associated Setd1 histone H3K4 methyltransferase complex. The ability of an exogenous promoter-less CpG-rich insertion to create de novo an H3K4me3 focus provides strong support for this notion. An attractive biological rationale for this phenomenon may be simplification of the large mammalian genome by the creation of 'beacons' of H3K4me3 that highlight CGI promoters within the genomic landscape 1 . Whether CpG clustering is sufficient to create stable non-methylated CGIs is uncertain. There is evidence that H3K4me3 is incompatible with de novo methylation as components of the DNA methyltransferase complex (Dnmt3L) are repelled by this modification 24 . In theory, therefore, Cfp1-bound CGIs should be intrinsically stable in the non-methylated state. Previous studies suggest, however, that transcription also has a role. Maintenance of non-methylated CGIs through the waves of de novo methylation in the early embryo depends on promoter function, as point mutations that prevent transcription factor binding without significantly reducing CpG density destroy the immunity of a CpG island to DNA methylation 25, 26 . It follows that H3K4 methylation due to CpG clustering may not be sufficient to reliably perpetuate the nonmethylated state. Indeed, more than half of cells carrying the promoter-less eGFP insertion at the Mecp2 locus had acquired dense methylation in ES cells despite the presence of a CpG cluster.
Our data suggest that chromatin modification need not arise secondarily as a result of, for example, transcriptional status, but can be determined genetically due to the sequence characteristics of a, Western blot analysis of non-methylated CGI and bulk chromatin released from purified nuclei using antibodies against selected histone modifications and CpG-binding proteins (normalized to histone H3 levels). An antibody against histone H3 served as a loading control. Modifications associated with transcriptional activity, including H3 acetylated on amino acids K9 and K14, H3K4me3 and H3K4me2 were enriched in CGI chromatin, whereas the elongation and silencing marks H3K36me3, H3K9me3, H3K27me3 and H4K20me3 were depleted. The CXXC domain proteins Cfp1 and Kdm2a also showed enrichment within the CGI fraction. were plated at low density and monitored at the times shown using a haemocytometer. Original magnification, 3200. d, ChIP qPCR using Cfp1, H3K4me3 and H3K27me3 antibodies at selected loci in vector-only control and Cfp1-depleted NIH3T3 cells. The results were replicated with an independent clone expressing the same shRNA combination (data not shown) and with each of two individual shRNA constructs (see Supplementary Fig. 3 ).
METHODS SUMMARY
Mouse brain nuclei were incubated with restriction enzymes and then pelleted to liberate small fragments of CGI chromatin that were then analysed by western blotting. ChIP was performed on mature mouse brain with antibodies against various chromatin proteins. Immunoprecipitated DNA was used for: (1) quantitative PCR (qPCR) analysis of specific loci; (2) bisulphite analysis to determine DNA methylation patterns; and (3) ligation of linkers and Solexa sequencing to identify sites of binding. To knockdown Cfp1, mouse NIH3T3 cells were transfected using shRNA targeting Cfp1 or vector alone as a control, and stable clones were selected by puromycin resistance. RNA and protein samples were prepared to verify the knockdown of Cfp1. For Fig. 3 , three shRNA were used in combination, but comparable results were obtained with two individual shRNAs ( Supplementary Fig. 3 ). ChIP with antibodies against Cfp1, H3K4me3 and H3K27me3 determined the effect of Cfp1 knockdown at four loci using qPCR. The eGFP insert was targeted to the Mecp2 locus by homologous recombination of a construct containing a PGK-Neo cassette flanked by loxP sites. Cre-mediated recombination was used to delete the selectable marker before bisulphite and ChIP analysis.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
